I87.2 I87.1 I87.9 R60
Conditions
Interventions
Group 1: Patients with chronic venous insufficiency with and without Ulcus cruris venosum and Oedama of other origin (compressiontherapy is indicated, see in- and exclusion criteria) will be treated w
Sponsors
PAUL HARTMANN AG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Application of PütterPro2 in typical indications within the scope of the specific purpose, inclusion criteria are therefore based essentially on the specifications of the manufacturer in the package insert. • Patient is maximum 18 years old • Patient is able to walk without walking frame and has no relevant restrictions in upper ankle • Patient is willing to use compression therapy according to the physicians prescription during the study period • Patient was informed about the study and gave written consent to participate in the study.
Exclusion criteria
Exclusion criteria: The exclusion criteria are also oriented on the specific purpose of the product. In addition, patients cannot be included in the study if: • the attending physician believes they are not able to understand the nature, significance and consequences of the planned study. • they have already been treated with PütterPro2 in the two weeks prior to the start of the observational study. • a pregnancy cannot be ruled out in female patients or if they are breastfeeding. • An allergy or intolerance of the patient to one or more substances of PütterPro2 is known.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| measurement of leg volume reduction by the watervolumendisplacement method and leg circumference | — |
Secondary
| Measure | Time frame |
|---|---|
| - collecting further experiences in the treatment with PütterPro2 - documentation of adverse device effect | — |
Countries
Germany
Contacts
Public ContactWiebke Schröder
Paul Hartmann AG
Outcome results
None listed